SCHEMBL24762913

SCHEMBL24762913

c1ccc(-c2nc(-c3ccccc3)nc(-c3cncc4oc5cc6ccccc6cc5c34)n2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
ESR1 P03372 2/20 0.34
ESR2 Q92731 2/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
HTT P42858 1/20 0.34
KDM4E B2RXH2 3/20 0.33
MAPT P10636 3/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
PRKCZ Q05513 1/20 0.33
ALDH1A1 P00352 3/20 0.33
TP53 P04637 2/20 0.33
HSD17B10 Q99714 2/20 0.33
TSHR P16473 2/20 0.33
CYP1A2 P05177 2/20 0.33
ADORA3 P0DMS8 1/20 0.33
ALOX15 P16050 1/20 0.33
ADORA2A P29274 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24762270 0.97 PRKCZ (0.35) SMN1; SMN2MEN1KMT2AESR1ESR2
SCHEMBL23944458 0.97 PRKCZ (0.35) SMN1; SMN2MEN1KMT2AESR1ESR2
SCHEMBL24762187 0.95 KDM4E (0.41) SMN1; SMN2MEN1KMT2ANPC1RAB9A
SCHEMBL23944804 0.94 PRKCZ (0.35) SMN1; SMN2MEN1KMT2AESR1ESR2
SCHEMBL23944559 0.94 KDM4E (0.40) SMN1; SMN2MEN1KMT2AESR1ESR2
SCHEMBL23944820 0.94 CYP11B1 (0.38) SMN1; SMN2MEN1KMT2AESR1ESR2
SCHEMBL23944378 0.93 PRKCZ (0.38) SMN1; SMN2MEN1KMT2ANPC1RAB9A
SCHEMBL23944537 0.93 KDM4E (0.39) SMN1; SMN2MEN1KMT2AESR1ESR2
SCHEMBL24762334 0.93 CYP11B1 (0.40) SMN1; SMN2MEN1KMT2AESR1ESR2
SCHEMBL23944358 0.92 PRKCZ (0.38) SMN1; SMN2MEN1KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220402928-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2022-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220402928-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CCNL2, CRY1, CRY2 SMN1; SMN2 2675/4885MEN1 1025/4885KMT2A 3186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.